| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Lynn N Gerber | Q63807250 |
| Ali A. Weinstein | Q43439666 | ||
| P2093 | author name string | Zobair M Younossi | |
| Rohini Mehta | |||
| P2860 | cites work | Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue and chronic fatigue syndrome: a prospective study in the primary care setting | Q71181863 |
| Psychometric qualities of a brief self-rated fatigue measure: The Fatigue Assessment Scale | Q73204607 | ||
| Vagal innervation of intestines: afferent pathways mapped with new en bloc horseradish peroxidase adaptation | Q80203316 | ||
| Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance | Q80687728 | ||
| Fatigue in primary biliary cirrhosis | Q81213657 | ||
| Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial) | Q86416747 | ||
| Fatigue in chronic liver disease: exploring the role of the autonomic nervous system | Q86529877 | ||
| Fatigue in chronic liver disease: New insights and therapeutic approaches | Q89209100 | ||
| An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers | Q57070812 | ||
| The Gut-Microglia Connection: Implications for Central Nervous System Diseases | Q57817925 | ||
| Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms | Q58122029 | ||
| Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver Disease | Q59335763 | ||
| Depression, fatigue and neurocognitive deficits in chronic hepatitis C | Q59358316 | ||
| Exercise and NAFLD: Is it worth the effort? | Q64904605 | ||
| Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study | Q68512879 | ||
| The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus | Q69772148 | ||
| Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection | Q24531350 | ||
| The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation | Q24807048 | ||
| Energy metabolism in the liver | Q26996783 | ||
| Reexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg effect | Q28077883 | ||
| Biomarkers and surrogate endpoints: preferred definitions and conceptual framework | Q28203935 | ||
| Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop | Q28263494 | ||
| Systemic symptoms in non-alcoholic fatty liver disease | Q33158731 | ||
| How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example | Q33454013 | ||
| Defining and measuring fatigue | Q33542308 | ||
| Lifestyle intervention involving calorie restriction with or without aerobic exercise training improves liver fat in adults with visceral adiposity | Q33594330 | ||
| Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments | Q33616887 | ||
| Predictors of long-term exercise adherence in a community-based sample of older women | Q33686954 | ||
| Identification of neuronal subpopulations that project from hypothalamus to both liver and adipose tissue polysynaptically | Q33859721 | ||
| The role of tryptophan in fatigue in different conditions of stress | Q33865357 | ||
| Cancer-Related Fatigue, Version 2.2015. | Q33878583 | ||
| Fatigue in chronic disease | Q33962371 | ||
| Fatigue in patients with diabetes: a review | Q34000723 | ||
| Fatigue and basal ganglia | Q34071789 | ||
| Cytokines in alcoholic and nonalcoholic steatohepatitis | Q34082594 | ||
| Fatigue in primary biliary cirrhosis | Q34114608 | ||
| NCCN Clinical Practice Guidelines Cancer-related fatigue | Q34140074 | ||
| Fatigue in neurological disorders | Q34308653 | ||
| Fatigue, depression and chronic hepatitis C infection | Q34554894 | ||
| Exercise therapy for chronic fatigue syndrome | Q34681695 | ||
| Cognitive fatigue defined in the context of attention networks | Q34684338 | ||
| Fatigue in cholestatic liver disease--a perplexing symptom | Q34769039 | ||
| Measuring substantial reductions in functioning in patients with chronic fatigue syndrome | Q35205590 | ||
| Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease | Q35356375 | ||
| An epidemiological approach to study fatigue in the working population: the Maastricht Cohort Study | Q35576720 | ||
| Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study | Q35598197 | ||
| Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment | Q35769113 | ||
| Fatigue complicating chronic liver disease | Q35956377 | ||
| Effects of Exhaustive Aerobic Exercise on Tryptophan-Kynurenine Metabolism in Trained Athletes | Q36002082 | ||
| Cancer-related fatigue--mechanisms, risk factors, and treatments | Q36332266 | ||
| Fatigue in liver disease: pathophysiology and clinical management | Q36426862 | ||
| The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression | Q36800963 | ||
| The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures. | Q37359250 | ||
| The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV). | Q37432877 | ||
| Future directions for investigation of fatigue in chronic hepatitis C viral infection | Q37497860 | ||
| Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients | Q37703523 | ||
| What is fatigue? Pathological and nonpathological fatigue | Q37775387 | ||
| Downregulated hypothalamic 5-HT3 receptor expression and enhanced 5-HT3 receptor antagonist-mediated improvement in fatigue-like behaviour in cholestatic rats | Q46964048 | ||
| Patients with primary biliary cholangitis and fatigue present with depressive symptoms and selected cognitive deficits, but with normal attention performance and brain structure. | Q47555624 | ||
| Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health | Q47659177 | ||
| Tryptophan circuit in fatigue: From blood to brain and cognition | Q47687012 | ||
| Complications, symptoms, quality of life and pregnancy in cholestatic liver disease. | Q48331749 | ||
| Well-being, cerebral function, and physical fatigue after nocturnal hypoglycemia in IDDM. | Q48491266 | ||
| Role of hepatic STAT3 in brain-insulin action on hepatic glucose production | Q48596967 | ||
| Factors related to fatigue in patients with cirrhosis before and after liver transplantation | Q48612716 | ||
| Comparison of self-reported fatigue in rheumatoid arthritis and controls | Q48822418 | ||
| Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease. | Q50721676 | ||
| The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue | Q52017423 | ||
| Development of a fatigue scale. | Q52038784 | ||
| Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. | Q53670137 | ||
| The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis. | Q54269133 | ||
| Central and peripheral fatigue: exemplified by multiple sclerosis and myasthenia gravis | Q37775394 | ||
| Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. | Q37993333 | ||
| Fatigue in healthy and diseased individuals | Q38124676 | ||
| Clinical relevance of fatigue as a residual symptom in major depressive disorder | Q38151637 | ||
| Liver-brain interactions in inflammatory liver diseases: implications for fatigue and mood disorders | Q38154026 | ||
| Role of exercise in optimizing the functional status of patients with nonalcoholic fatty liver disease. | Q38166057 | ||
| Physical activity and liver diseases | Q38574957 | ||
| Understanding and Treating Fatigue in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis | Q38642929 | ||
| Depression, Serotonin and Tryptophan | Q38665602 | ||
| Advancing Symptom Science Through Symptom Cluster Research: Expert Panel Proceedings and Recommendations | Q38766256 | ||
| Therapies in non-alcoholic steatohepatitis (NASH). | Q38774861 | ||
| Neural Contributions to Muscle Fatigue: From the Brain to the Muscle and Back Again | Q38785028 | ||
| Exercise and other non-pharmaceutical interventions for cancer-related fatigue in patients during or after cancer treatment: a systematic review incorporating an indirect-comparisons meta-analysis. | Q38787544 | ||
| Role of the Kynurenine Metabolism Pathway in Inflammation-Induced Depression: Preclinical Approaches | Q38844375 | ||
| Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review. | Q38911269 | ||
| Demonstration of two types of fatigue in subjects with chronic liver disease using factor analysis | Q38948929 | ||
| Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review | Q38957683 | ||
| Liver inflammation and fibrosis | Q39065620 | ||
| Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis | Q39128760 | ||
| Exercise training reverses endothelial dysfunction in nonalcoholic fatty liver disease | Q39134033 | ||
| Treatment of NAFLD with diet, physical activity and exercise. | Q39331043 | ||
| Prevalence of fatigue and chronic fatigue syndrome in a primary care practice | Q39404755 | ||
| Fatigue as a residual symptom of depression | Q39409368 | ||
| Altered central serotoninergic neurotransmission: a potential mechanism for profound fatigue complicating chronic hepatitis C. | Q39416602 | ||
| Patient-Reported Outcomes and Fatigue in Patients with Chronic Hepatitis C Infection. | Q39423731 | ||
| Nonalcoholic fatty liver disease and measures of early brain health in middle-aged adults: The CARDIA study | Q40346519 | ||
| Effects of Viral Eradication With Ledipasvir and Sofosbuvir, With or Without Ribavirin, on Measures of Fatigue in Patients With Chronic Hepatitis C Virus Infection | Q40661767 | ||
| Central fatigue. Critical issues, quantification and practical implications | Q40960732 | ||
| Fatigue in chronic hepatitis C infection: Understanding patients' experience from a cognitive-behavioural perspective | Q41065454 | ||
| Neuroendocrine correlates of chronic fatigue syndrome: a brief review | Q41513702 | ||
| The importance of fatigue cognitions in chronic hepatitis C infection | Q41643043 | ||
| A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease | Q42379258 | ||
| Inhibition of IL-1beta improves fatigue in type 2 diabetes. | Q42919291 | ||
| Fatigue in patients with chronic hepatitis C. | Q43549742 | ||
| Central monoamine and plasma corticosterone changes induced by a bacterial endotoxin: sensitization and cross-sensitization effects | Q43563930 | ||
| Validity and reliability of a scale to assess fatigue | Q44932790 | ||
| Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-Aged Adults in the Framingham Study. | Q46030301 | ||
| Depression, fatigue, and functional disability in patients with chronic hepatitis C. | Q46556569 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P433 | issue | 28 | |
| P921 | main subject | chronic liver disease | Q5113984 |
| fatigue | Q9690 | ||
| energy metabolism | Q30225378 | ||
| P304 | page(s) | 3669-3683 | |
| P577 | publication date | 2019-07-01 | |
| 2019-07-28 | |||
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Importance of fatigue and its measurement in chronic liver disease | |
| P478 | volume | 25 |
| Q89947398 | Importance of Monitoring Physical Function for Quality of Life Assessments in Hematopoietic Stem Cell Transplantation Patients: A Prospective Cohort Study | cites work | P2860 |
Search more.